Simplified Chinese
scroll down
01
2024-03
My father has hepatitis B—can he pass it on to the baby?
Article excerpted from “Liver Doctor”: Common routes of hepatitis B transmission include vertical transmission, bloodborne transmission, and sexual transmission. In China, mother-to-child transmission is the primary mode of infection and a major reason why the country has such a large and persistent population of chronic hepatitis B carriers. In recent years, awareness among women of childbearing age regarding maternal–infant transmission prevention has improved significantly. Many patients wonder: if the risk of mother-to-child transmission is high without intervention, can a father with chronic hepatitis B also pass the virus to his children? How contagious is it, and what preventive measures should be taken? Can it be transmitted? The answer is yes. As early as 1987, foreign researchers discovered that artificial…
05
2024-01
Recently, the National Intellectual Property Administration issued the “Notice of the National Intellectual Property Administration on Designating the New Batch of 2023 and the Re‑certified National Intellectual Property Demonstration Enterprises and Advantageous Enterprises.” Beijing Minhai Biotechnology Co., Ltd. has been recognized as a “National Intellectual Property Demonstration Enterprise.” Image source: Official website of the National Intellectual Property Administration. A National Intellectual Property Demonstration Enterprise is an enterprise that embodies a strategic approach to intellectual property management, demonstrates well‑rounded capabilities in IP creation, utilization, protection, and administration, possesses distinct comprehensive competitive advantages in the field, and serves as a benchmark with significant industry influence. This designation represents the highest honor the state confers for outstanding IP management practices.
20
2023-12
On December 11, 2023, Beijing Minhai Biotechnology Co., Ltd., a wholly owned subsidiary of Kangtai Biological, signed the “License and Technology Transfer Agreement for the 13‑Valent Pneumococcal Polysaccharide Conjugate Vaccine” with the Egyptian vaccine company Gennvax Egypt. The two parties have entered into a commercial partnership to grant licensing and transfer technology for Minhai Biotechnology’s independently developed and manufactured world’s first dual‑carrier 13‑valent pneumococcal polysaccharide conjugate vaccine, jointly advancing the approval and market launch of the finished vaccine in Egypt, as well as local bulk‑fill and finish operations. The signing ceremony was held ceremoniously at the Beijing Minhai International New‑Type Vaccine Internationalization Industrial Base, attended by Minhai’s general manager.
15
2023-11
On November 14, 2023, a delegation led by Hao Zehong, member of the Party Leadership Group and Vice Chairman of the Daxing District Federation of Trade Unions, along with Han Fengguang, head of the Rights and Interests Department of the Daxing District Federation of Trade Unions, paid a visit to Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as Minhai Bio) to conduct a supervisory inspection as part of the special initiative to promote amendments to the “Beijing Municipal Collective Contract Regulations.” Members of the collective bargaining guidance team and relevant officials from the trade union of the biopharmaceutical industrial base also attended the inspection. Wang Hui, Assistant General Manager of Minhai Bio, Zhang Ning, Deputy Manager of the Human Resources Department, Ma Hongjuan, Vice Chairwoman of the trade union, and other related personnel accompanied the delegation. Assistant General Manager Wang Hui briefed the inspection team on Minhai Bio’s efforts regarding collective bargaining…
10
2023-11
At 11:08 a.m. on November 9, 2023, a grand ribbon-cutting ceremony was held in front of the restaurant at the Minhai International Industrial Base. The event was meticulously planned by the company’s General Office Logistics Department, and attended by relevant leaders and employees, including General Manager Zheng Haifa, Deputy General Manager Nie Xiaoqi, Vice President of Engineering Li Guanghui, Deputy Director of Production and Head of Vaccine Room No. 3 Tong Wei, as well as Assistant to the General Manager and HR Manager Wang Hui. During the ceremony, Deputy General Manager Nie emphasized that relocating the restaurant is a crucial step in the company’s broader move to the international industrial base. He noted that this initiative reflects the company’s care for its employees, aims to improve the dining environment, and enhance staff satisfaction, while also serving as a source of motivation for all.
Contact Information
Customer Service Hotline
4001899806
Phone number
010-59613600
Official Website
Company Address
No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
WeChat Official Account
0
%